Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
11.90
-0.13 (-1.08%)
At close: Mar 28, 2024, 4:00 PM
12.15
+0.25 (2.10%)
After-hours: Mar 28, 2024, 7:54 PM EDT

Annovis Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Cash & Equivalents
28.3845.698.0700.04
Cash & Cash Equivalents
28.3845.698.0700.04
Cash Growth
-37.89%465.80%434488.70%-94.74%-
Receivables
0000.740
Other Current Assets
7.640.320.040.010.02
Total Current Assets
36.02468.120.750.05
Other Long-Term Assets
0000.370
Total Long-Term Assets
0000.370
Total Assets
36.02468.121.120.05
Accounts Payable
3.960.690.341.230.07
Other Current Liabilities
3.740.820.240.780.5
Total Current Liabilities
7.71.510.582.010.57
Long-Term Debt
0000.50
Other Long-Term Liabilities
0000.110
Total Long-Term Liabilities
0000.610
Total Liabilities
7.71.510.582.620.57
Total Debt
0000.50
Retained Earnings
-54.05-28.73-14.24-8.78-7.79
Shareholders' Equity
28.3244.497.54-8.58-7.59
Net Cash / Debt
28.3845.698.07-0.50.04
Net Cash / Debt Growth
-37.89%465.80%---
Net Cash Per Share
3.485.991.28-1.760.13
Working Capital
28.3244.497.54-1.26-0.52
Book Value Per Share
3.475.831.20-30.35-27.36
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).